"Established in 2015, SIBIONICS is dedicated to the research, development, and industrialization of groundbreaking medical devices for chronic disease management. With a workforce of over 700 employees, the company has diligently pursued its mission of "Advancing medical technology, promoting public health."
In 2025, we obtained the CE Mark for the SIBIONICS GS3 CGM(Continuous Glucose Monitoring) system. This CGM system offers users a 14-day, calibration-free glucose monitoring solution, enabling them to transmit glucose data to monitoring devices or mobile apps and generate professional AGP reports. Additionally, it supports data sharing with friends and family and integrates seamlessly with the advanced ProView remote access platform."